Erg Bio Inc.

Erg Bio Inc. , based in the US, specializes in transforming waste biomass into high-value products, focusing on fermentable sugars for synthetic aviation fuels and sustainable chemicals. Founded in 2023 in Dublin, US, Erg Bio Inc. focuses on the conversion of waste biomass into valuable products.

The firm has completed one deal, raising USD 6. 5 mn in a SEED funding round led by Azolla Ventures on November 18, 2025, including Chevron Technology Ventures, Freeflow Ventures, and Plug and Play. Erg Bio specializes in the conversion of waste biomass into high-value products, primarily focusing on fermentable sugars and intermediates for synthetic aviation fuels and cost-competitive chemicals. Their core technology leverages advanced solvents and proprietary yeast capable of producing cellulase and hemicellulase enzymes, facilitating the fermentation of sugars into ethanol.

The innovative processes have been tested across over 40 different feedstocks, addressing significant waste in the U. S. bioeconomy and enhancing supply chain resilience. Erg Bio primarily targets markets in North America and Europe, serving clients in the energy, chemical, and biomanufacturing sectors.

Erg Bio generates revenue through partnerships and direct sales of its technology to businesses engaged in biofuels and bioproducts manufacturing. The transaction structure typically involves B2B arrangements where clients purchase access to the company's patented technology for processing biomass, often including terms for ongoing support. In November 2025, Erg Bio Inc. raised USD 6.

5 mn in seed funding to further enhance its Aspire™ Technology. The company plans to expand into new markets and geographic regions, focusing on North America and Europe, leveraging its innovative solutions. This funding will support the development of new products and technology advancements, contributing to its growth strategy.